Consultation on licence applications for release of genetically modified organisms into the environment

Steps in the evaluation process

Notification of receipt of application - These notices provide advice that a DIR licence application has been received by the OGTR and that a RARMP is in preparation.

Public calls for comment - The Regulator has invited the public to provide comment on a RARMP regarding the identified risk(s) to human health and the environment and the proposed management measures.

Call for comment closed - Comments on these RARMPs have closed, the Regulator is considering submissions and a decision on the licence is imminent.

For more information about DIR applications, please contact the OGTR. DIR applications are available on request (excluding any information that the Regulator has declared to be, or is under consideration as, Confidential Commercial Information) to anyone that requests a copy (section 54 of the Act). A summary of application and, once prepared, the RARMP for each application is available on this website.

Represents the status of licence applications and includes links to the relevant documents

DIR Licence Application Number	Title of Project	Notification of receipt of application	Public calls for comment on RARMP open	Call for comment closed (under consideration by the Regulator)	Is application being assessed as ‘limited and controlled’?
DIR 174	Commercial supply of a genetically modified cholera vaccine, Vaxchora®	27 May 2020			No
DIR 173	Commercial release of cotton genetically modified for herbicide tolerance (MON 88701)	16 Mar 2020			No

View the list of DIRs.